Subtype
Cervical Neoplasm
CI-CAN-00004801Explore in graph →
Non-malignant573 active trials4 approved drugs14 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004801Explore in graph →
Clinical trials
2,386 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05068921 | A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy | unknown | Phase 1 | 40 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 13, 2021 | clinicaltrials |
| NCT05059015 | Human Papilloma Virus (HPV) Self-collection and Women Adherence | unknown | N/A | 80 | Instituto Nacional de Cancerologia, ColumbiaOTHER_GOV | 1 | Dec 10, 2021 |
| NCT05151549 | A Study of Carilizumab Combined With Concurrent Chemoradiotherapy | unknown | Phase 2 | 46 | Hunan Cancer HospitalOTHER | 0 | Dec 9, 2021 | clinicaltrials |
| NCT05137171 | AK105 Combined With Anlotinib in Patients With Cervical Cancer | unknown | Phase 2 | 36 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 0 | Nov 30, 2021 | clinicaltrials |
| NCT04443296 | Study of Tumor Infiltrating Lymphocytes Following CCRT in the Treatment of Patients With Cervical Carcinoma(TIL-Cx) | unknown | Phase 1 | 10 | Sun Yat-sen UniversityOTHER | 1 | Nov 16, 2021 | clinicaltrials |
| NCT04934982 | Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)(LAUNCH 1) | unknown | N/A | 690 | Hua JiangOTHER | 1 | Nov 10, 2021 | clinicaltrials |
| NCT04939831 | Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB3,IIA2)(LAUNCH 3) | unknown | N/A | 1,104 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Nov 10, 2021 | clinicaltrials |
| NCT04214964 | Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study | unknown | — | 10,000 | Tongji HospitalOTHER | 1 | Oct 7, 2021 | clinicaltrials |
| NCT05065853 | Urinary and Vaginal HPV Testing in Cervical Cancer Screening | unknown | — | 330 | University of AarhusOTHER | 0 | Oct 4, 2021 | clinicaltrials |
| NCT00108745 | Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer | unknown | Phase 3 | 1,157 | GOG FoundationNETWORK | 1 | Sep 30, 2021 | clinicaltrials |
| NCT02388698 | FDG-PET and Circulating HPV in Patients With Cervical Cancer | unknown | N/A | 84 | Sunnybrook Health Sciences CentreOTHER | 1 | Sep 22, 2021 | clinicaltrials |
| NCT04731038 | Combination Therapy for First Line Treatment of Advanced Cervical Cancer | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Sep 17, 2021 | clinicaltrials |
| NCT00980759 | Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer | unknown | N/A | 312 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 8, 2021 | clinicaltrials |
| NCT04238988 | Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer(MITO CERV 3) | unknown | Phase 2 | 45 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT05013268 | Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma(TiTanec) | unknown | Phase 1 | 15 | Ruijin HospitalOTHER | 1 | Aug 24, 2021 | clinicaltrials |
| NCT04974827 | A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer | unknown | Phase 2 | 46 | Hunan Cancer HospitalOTHER | 1 | Aug 10, 2021 | clinicaltrials |
| NCT04974424 | Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV | unknown | — | 20,000 | Huazhong University of Science and TechnologyOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT04973904 | Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer | unknown | Phase 2 | 35 | Peking Union Medical College HospitalOTHER | 1 | Jul 22, 2021 | clinicaltrials |
| NCT03321461 | TMTP1-ICG Mapping in Colposcopy-directed Biopsy | unknown | Phase 1 | 40 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 30, 2021 | clinicaltrials |
| NCT04905030 | Education, Immigration and HPV Vaccination: an Informational Randomized Trial | unknown | N/A | 2,500 | Karolinska InstitutetOTHER | 1 | Jun 11, 2021 | clinicaltrials |
| NCT04918628 | Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer(CRTCP) | unknown | Phase 2 | 50 | Taizhou HospitalOTHER | 1 | Jun 9, 2021 | clinicaltrials |
| NCT04556669 | Anti-PD-L1 Armored Anti-CD22 CAR-T/CAR-TILs Targeting Patients With Solid Tumors | unknown | Phase 1 | 30 | Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY | 1 | May 27, 2021 | clinicaltrials |
| NCT04395612 | Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer(CQGOG0101) | unknown | Phase 2 | 38 | Chongqing University Cancer HospitalOTHER | 1 | May 21, 2021 | clinicaltrials |
| NCT03676959 | A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Recurrent or Metastatic Cervical Cancer | unknown | Phase 1 | 101 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | May 13, 2021 | clinicaltrials |
| NCT04884906 | Camrelizumab Combined With Radiotherapy and Chemotherapy for the Treatment of Recurrent or Metastatic Cervical Cancer | unknown | Phase 2 | 40 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT04859361 | Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ | unknown | N/A | 104 | University Medical Centre MariborOTHER | 1 | May 3, 2021 | clinicaltrials |
| NCT03852823 | Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours | unknown | Phase 1 | 192 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd.INDUSTRY | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04868097 | Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2 | unknown | N/A | 52 | Kaplan Medical CenterOTHER | 1 | Apr 30, 2021 | clinicaltrials |
| NCT04819685 | Application of KANG FU PEN in Radical Concurrent Radiotherapy and Chemotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Rectal Injury | unknown | Phase 4 | 520 | Peking Union Medical College HospitalOTHER | 1 | Mar 29, 2021 | clinicaltrials |
| NCT00920920 | An International Study on Magnetic Resonance Imaging (MRI)-Guided Brachytherapy in Locally Advanced Cervical Cancer(EMBRACE) | unknown | — | 1,416 | Medical University of ViennaOTHER | 1 | Mar 25, 2021 | clinicaltrials |
| NCT03000192 | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | unknown | — | 3,000 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04461574 | Orcellex® Brush Versus Cervex-Brush® on Vault Smear Adequacy in Patients Treated With Radiotherapy for Cervical Cancer | unknown | N/A | 160 | Princess Margaret Hospital, Hong KongOTHER_GOV | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04800978 | Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy | unknown | Phase 2 | 37 | Samsung Medical CenterOTHER | 0 | Mar 16, 2021 | clinicaltrials |
| NCT04789941 | How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer Cervix | unknown | Phase 2 | 50 | Assiut UniversityOTHER | 0 | Mar 10, 2021 | clinicaltrials |
| NCT04783649 | Clinical Validation of Cervical Cancer Screening Methods | unknown | — | 2,500 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT03808857 | A Study in Recurrent or Metastatic Cervical Cancer Patients With PD-L1 Positive | unknown | Phase 2 | 80 | Genor Biopharma Co., Ltd.INDUSTRY | 1 | Mar 3, 2021 | clinicaltrials |
| NCT04508686 | Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1) | unknown | Phase 1 | 20 | Ruijin HospitalOTHER | 1 | Jan 29, 2021 | clinicaltrials |
| NCT02624531 | Prospective Study of Fertility-sparing Treatment Strategy in Patients With Early Cervical Cancer(SYSUGO-005/CSEM009)(SYSUGO-005) | unknown | N/A | 60 | Sun Yat-sen UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT04695535 | Chemotherapy With Anlotinib in Advanced Cervical Cancer | unknown | — | 10 | Yang ShenOTHER | 1 | Jan 5, 2021 | clinicaltrials |
| NCT04691453 | QM-B and QM-C Hysterectomy for Early Cervical Cancer(QMBCHECC) | unknown | N/A | 538 | Southern Medical University, ChinaOTHER | 1 | Dec 31, 2020 | clinicaltrials |
| NCT00454766 | Evaluating Materials to Educate Patients About Cervical Dysplasia | unknown | — | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT04664244 | Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma | unknown | Phase 2 | 43 | Lei LiOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT04678791 | Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma | unknown | N/A | 286 | Peking University Third HospitalOTHER | 1 | Dec 22, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT04650711 | Immunohistochemical Staining of p16 for the Screening of Cervical Cancer | unknown | Phase 2 | 250 | Lei LiOTHER | 1 | Dec 3, 2020 | clinicaltrials |
| NCT04646954 | DNA Methylation Testing for the Screening of Uterine Cervical Lesion | unknown | Phase 3 | 12,000 | Lei LiOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT03961412 | A Family-based Intervention to Improve Pap Test Screening Among Under-screened Chinese American Immigrant Women | unknown | Early Phase 1 | 224 | University of Nevada, RenoOTHER | 0 | Nov 24, 2020 | clinicaltrials |
| NCT04635956 | Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas | unknown | Phase 2 | 20 | Lei LiOTHER | 1 | Nov 19, 2020 | clinicaltrials |
| NCT04114968 | Offering Cervical Cancer Screening to Older Women | unknown | — | 20,000 | University of AarhusOTHER | 1 | Nov 6, 2020 | clinicaltrials |
| NCT03931083 | Screening Test Accuracy of Gynocular™, HR-HPV Testing, VIA for Detection of Cervical Neoplastic Lesions, in Women Living With HIV | unknown | — | 450 | University of BernOTHER | 1 | Nov 3, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Dec 13, 2021source: clinicaltrials